Insider Trading & Ownership - Zentalis Pharmaceuticals Inc. (ZNTL)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Zentalis Pharmaceuticals Inc.
Goto Prev, 0, 1, 2, 3, 4, 5, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-10-04
Sale
2023-10-06
7:18 pm
Zentalis Pharmaceuticals Inc. ZNTL Epperly Melissa B
Chief Financial Officer
5,482 $19.5 $106,926 387,691
(Direct)
View
2023-09-11
Sale
2023-09-13
4:11 pm
Zentalis Pharmaceuticals Inc. ZNTL Skvarka Jan
Director
5,000 $25.05 $125,238 47,970
(Direct)
View
2023-06-20
Purchase
2023-06-20
4:30 pm
Zentalis Pharmaceuticals Inc. ZNTL Matrix Capital Management Company LP
GOEL DAVID E.
10% Owner
4,760,000 $22.66 $107,861,600 13,959,973
(Indirect)
View
2023-05-31
Sale
2023-05-31
9:10 pm
Zentalis Pharmaceuticals Inc. ZNTL Gallagher Cam
President
27,768 $26.27 $729,506 463,502
(Direct)
View
2023-05-26
Sale
2023-05-31
9:09 pm
Zentalis Pharmaceuticals Inc. ZNTL Bunker Kevin D.
Chief Scientific Officer
80,000 $30.02 $2,401,248 880,507
(Indirect
Direct)
View
2023-02-13
Sale
2023-02-14
7:10 pm
Zentalis Pharmaceuticals Inc. ZNTL Epperly Melissa B
Chief Financial Officer
7,851 $20.13 $158,005 392,048
(Direct)
View
2023-02-13
Sale
2023-02-14
7:09 pm
Zentalis Pharmaceuticals Inc. ZNTL Gallagher Cam
President
11,833 $20.09 $237,760 491,270
(Direct)
View
2023-02-13
Sale
2023-02-14
7:07 pm
Zentalis Pharmaceuticals Inc. ZNTL Bunker Kevin D.
Chief Scientific Officer
10,307 $20.14 $207,629 960,507
(Indirect
Direct)
View
2023-02-06
Sale
2023-02-06
7:36 pm
Zentalis Pharmaceuticals Inc. ZNTL Gallagher Cam
President
10,000 $22.27 $222,678 503,103
(Direct)
View
2023-01-17
Sale
2023-01-18
5:15 pm
Zentalis Pharmaceuticals Inc. ZNTL Gallagher Cam
President
10,000 $24.15 $241,515 352,011
(Direct)
View
2023-01-05
Sale
2023-01-05
7:16 pm
Zentalis Pharmaceuticals Inc. ZNTL Gallagher Cam
President
10,000 $21.02 $210,228 362,011
(Direct)
View
2022-11-15
Sale
2022-11-15
7:50 pm
Zentalis Pharmaceuticals Inc. ZNTL Gallagher Cam
President
12,500 $22.77 $284,683 372,011
(Direct)
View
2022-11-07
Sale
2022-11-08
8:38 pm
Zentalis Pharmaceuticals Inc. ZNTL Gallagher Cam
President
24,874 $23.62 $587,403 384,511
(Direct)
View
2022-10-17
Sale
2022-10-17
9:02 pm
Zentalis Pharmaceuticals Inc. ZNTL Gallagher Cam
President
12,500 $23.51 $293,879 409,385
(Direct)
View
2022-10-05
Sale
2022-10-07
4:40 pm
Zentalis Pharmaceuticals Inc. ZNTL Gallagher Cam
President
22,500 $22.45 $505,186 421,885
(Direct)
View
2022-09-15
Sale
2022-09-16
8:25 pm
Zentalis Pharmaceuticals Inc. ZNTL Gallagher Cam
President
22,500 $24.9 $560,254 444,385
(Direct)
View
2022-08-10
Sale
2022-08-12
4:26 pm
Zentalis Pharmaceuticals Inc. ZNTL Bunker Kevin D.
Chief Operating Officer
5,000 $30 $150,000 859,460
(Indirect
Direct)
View
2022-07-20
Sale
2022-07-20
8:28 pm
Zentalis Pharmaceuticals Inc. ZNTL Bunker Kevin D.
Chief Operating Officer
5,000 $30 $150,000 864,460
(Indirect
Direct)
View
2022-07-13
Sale
2022-07-14
6:37 pm
Zentalis Pharmaceuticals Inc. ZNTL Bunker Kevin D.
Chief Operating Officer
5,000 $30.01 $150,062 869,460
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-06-16
Option Award
2023-06-16
5:04 pm
N/A
N/A
Zentalis Pharmaceuticals Inc. ZNTL Johnson David Michael
Director
19,059 $0 127,389
(Direct)
View
2023-06-16
Option Award
2023-06-16
5:02 pm
N/A
N/A
Zentalis Pharmaceuticals Inc. ZNTL Kariuki Enoch
Director
16,364 $0 38,181
(Direct)
View
2023-06-16
Option Award
2023-06-16
5:01 pm
N/A
N/A
Zentalis Pharmaceuticals Inc. ZNTL Skvarka Jan
Director
16,364 $0 52,970
(Direct)
View
2023-05-08
Option Award
2023-05-10
07:13 am
N/A
N/A
Zentalis Pharmaceuticals Inc. ZNTL HAUSMAN DIANA
Director
39,732 $0 39,732
(Direct)
View
2023-03-01
Option Award
2023-03-02
4:30 pm
N/A
2033-03-01
Zentalis Pharmaceuticals Inc. ZNTL Roth Iris
Chief Operating Officer
350,000 $0 350,000
(Direct)
View
2023-02-01
Option Award
2023-02-01
7:09 pm
N/A
2033-01-31
Zentalis Pharmaceuticals Inc. ZNTL Bunker Kevin D.
Chief Scientific Officer
224,000 $0 1,103,460
(Direct)
View
2022-11-09
Gift
2023-02-01
7:09 pm
N/A
N/A
Zentalis Pharmaceuticals Inc. ZNTL Bunker Kevin D.
Chief Scientific Officer
30,000 $0 1,103,460
(Direct)
View
2023-02-01
Option Award
2023-02-01
7:08 pm
N/A
2033-01-31
Zentalis Pharmaceuticals Inc. ZNTL Gallagher Cam
President
395,000 $0 747,011
(Direct)
View
2023-02-01
Option Award
2023-02-01
7:08 pm
N/A
2033-01-31
Zentalis Pharmaceuticals Inc. ZNTL Blackwell Kimberly
Chief Executive Officer
600,000 $0 605,000
(Direct)
View
2023-02-01
Option Award
2023-02-01
7:07 pm
N/A
2033-01-31
Zentalis Pharmaceuticals Inc. ZNTL Epperly Melissa B
Chief Financial Officer
250,000 $0 547,942
(Direct)
View
2023-02-01
Option Award
2023-02-01
7:06 pm
N/A
2033-01-31
Zentalis Pharmaceuticals Inc. ZNTL Paul Andrea
General Counsel
100,000 $0 100,000
(Direct)
View
2023-02-01
Option Award
2023-02-01
7:06 pm
N/A
2033-01-31
Zentalis Pharmaceuticals Inc. ZNTL Brownstein Carrie
Chief Medical Officer
40,000 $0 140,000
(Direct)
View
2022-10-03
Option Award
2022-10-03
6:42 pm
N/A
N/A
Zentalis Pharmaceuticals Inc. ZNTL Epperly Melissa B
Chief Financial Officer
50,000 $0 297,543
(Direct)
View
2022-10-03
Option Award
2022-10-03
6:40 pm
N/A
2032-10-02
Zentalis Pharmaceuticals Inc. ZNTL Bunker Kevin D.
Chief Scientific Officer
50,000 $0 959,460
(Direct)
View
2022-10-03
Option Award
2022-10-03
6:37 pm
N/A
2032-10-02
Zentalis Pharmaceuticals Inc. ZNTL Brownstein Carrie
Chief Medical Officer
400,000 $0 500,000
(Direct)
View
2022-09-09
Option Award
2022-09-12
07:07 am
N/A
N/A
Zentalis Pharmaceuticals Inc. ZNTL Skvarka Jan
Director
36,606 $0 36,606
(Direct)
View
2022-08-01
Option Award
2022-08-01
5:28 pm
N/A
2032-07-31
Zentalis Pharmaceuticals Inc. ZNTL Paul Andrea
General Counsel
290,500 $0 290,500
(Direct)
View
Goto Prev, 0, 1, 2, 3, 4, 5, Next